CNBC Africa | Closing Bell
Stephen Saad | Fifi Peters
Positive market reaction resulting in a double digit increase, 20% rise in EBITDA, exceptional operational performance across business segments, and forex effects on the balance sheet were discussed. The demand and prospects for GLP-1s and the successful launch of Mounjaro which claimed 20% market share in January, were also highlighted.